Dr. Galsky on a Post-Treatment Nomogram in Urothelial Cancer

Video

Matthew D. Galsky, MD, from the Mount Sinai Medical Center Tisch Cancer Institute, discusses the development of a post-treatment prognostic model for patients with metastatic urothelial cancer.

Matthew D. Galsky, MD, director, Genitourinary Medical Oncology, associate medical director, Cancer Clinical Trials Office, Mount Sinai Medical Center, The Tisch Cancer Institute, discusses the development of a post-treatment prognostic model following treatment with first-line chemotherapy for patients with metastatic urothelial cancer.

Data was pooled from 317 patients who were enrolled in 8 clinical trials that were evaluating first-line cisplatin in metastatic urothelial cancer. To create the post-treatment nomogram, established pretreatment variables were combined with response to treatment, the duration of chemotherapy, and the reason for stopping treatment.

The duration of treatment and treatment discontinuation were not found to correlate with changes in survival, Galsky notes. Overall, the only post-treatment factor that was associated with survival was response to chemotherapy. Following an independent validation, the nomogram contained 4 indicators: response to chemotherapy, number of visceral metastatic sites, ECOG performance status, and whole blood cell counts.

Galsky believes these findings are particularly important for patients who want to know what comes next after treatment. Additionally, it may help select patients who are eligible to participate in maintenance therapy trials.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD